Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer’s disease: study partner vs. participant accuracy

BACKGROUND: Preclinical Alzheimer’s disease (AD) clinical trials require participants to enroll with a study partner, a person who can attend visits and report changes in the participant’s cognitive ability. Whether study partners, compared to participants themselves, provide added information about...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Mary M., Grill, Joshua D., Gillen, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800492/
https://www.ncbi.nlm.nih.gov/pubmed/31627738
http://dx.doi.org/10.1186/s13195-019-0539-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800492/
https://www.ncbi.nlm.nih.gov/pubmed/31627738
http://dx.doi.org/10.1186/s13195-019-0539-3

Ejemplares similares